Clinical Trial Update: Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO [Phase 2]

View source ↗

Summary

Phase 2 pre-operative breast cancer trial evaluating nivolumab in combination with a novel immuno-oncology agent; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Novel IO (investigational immuno-oncology agent)
• nivolumab (nivolumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING